132 related articles for article (PubMed ID: 16675176)
21. pH-sensitive microsphere delivery increases oral bioavailability of calcitonin.
Lamprecht A; Yamamoto H; Takeuchi H; Kawashima Y
J Control Release; 2004 Jul; 98(1):1-9. PubMed ID: 15245884
[TBL] [Abstract][Full Text] [Related]
22. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic and immunosuppressive effects of tacrolimus-loaded biodegradable microspheres.
Miyamoto Y; Uno T; Yamamoto H; Xiao-Kang L; Sakamoto K; Hashimoto H; Takenaka H; Kawashima Y; Kawarasaki H
Liver Transpl; 2004 Mar; 10(3):392-6. PubMed ID: 15004766
[TBL] [Abstract][Full Text] [Related]
24. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
25. Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery.
Shin SB; Cho HY; Kim DD; Choi HG; Lee YB
Eur J Pharm Biopharm; 2010 Feb; 74(2):164-71. PubMed ID: 19703559
[TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
27. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN
J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839
[TBL] [Abstract][Full Text] [Related]
28. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.
Dai J; Nagai T; Wang X; Zhang T; Meng M; Zhang Q
Int J Pharm; 2004 Aug; 280(1-2):229-40. PubMed ID: 15265562
[TBL] [Abstract][Full Text] [Related]
29. An arachidonic acid-enriched diet does not result in more colonic inflammation as compared with fish oil- or oleic acid-enriched diets in mice with experimental colitis.
Ramakers JD; Mensink RP; Verstege MI; te Velde AA; Plat J
Br J Nutr; 2008 Aug; 100(2):347-54. PubMed ID: 18205994
[TBL] [Abstract][Full Text] [Related]
30. Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway.
Shamshiri H; Paragomi P; Paydar MJ; Moezi L; Bahadori M; Behfar B; Ardalan FA; Dehpour AR
J Gastroenterol Hepatol; 2009 Apr; 24(4):672-80. PubMed ID: 19032458
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of tacrolimus in inhibiting inflammation caused by carrageenan in a murine model of air pouch.
Vigil SV; de Liz R; Medeiros YS; Fröde TS
Transpl Immunol; 2008 Apr; 19(1):25-9. PubMed ID: 18346634
[TBL] [Abstract][Full Text] [Related]
32. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
[TBL] [Abstract][Full Text] [Related]
33. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
34. Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease.
Punekar S; Zak S; Kalter VG; Dobransky L; Punekar I; Lawler JW; Gutierrez LS
Pathobiology; 2008; 75(1):9-21. PubMed ID: 18334835
[TBL] [Abstract][Full Text] [Related]
35. Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate.
Kajiya M; Silva MJ; Sato K; Ouhara K; Kawai T
Biochem Biophys Res Commun; 2009 Aug; 386(1):11-5. PubMed ID: 19486890
[TBL] [Abstract][Full Text] [Related]
36. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease.
Khalil PN; Weiler V; Nelson PJ; Khalil MN; Moosmann S; Mutschler WE; Siebeck M; Huss R
Gastroenterology; 2007 Mar; 132(3):944-54. PubMed ID: 17383423
[TBL] [Abstract][Full Text] [Related]
37. The opioid antagonist naltrexone improves murine inflammatory bowel disease.
Matters GL; Harms JF; McGovern C; Fitzpatrick L; Parikh A; Nilo N; Smith JP
J Immunotoxicol; 2008 Apr; 5(2):179-87. PubMed ID: 18569389
[TBL] [Abstract][Full Text] [Related]
38. Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13)--a novel approach for the treatment of inflammatory bowel disease.
Bank U; Heimburg A; Helmuth M; Stefin S; Lendeckel U; Reinhold D; Faust J; Fuchs P; Sens B; Neubert K; Täger M; Ansorge S
Int Immunopharmacol; 2006 Dec; 6(13-14):1925-34. PubMed ID: 17161345
[TBL] [Abstract][Full Text] [Related]
39. Lectin-decorated nanoparticles enhance binding to the inflamed tissue in experimental colitis.
Moulari B; Béduneau A; Pellequer Y; Lamprecht A
J Control Release; 2014 Aug; 188():9-17. PubMed ID: 24910194
[TBL] [Abstract][Full Text] [Related]
40. Nanoparticle-based oral drug delivery system for an injectable antibiotic - streptomycin. Evaluation in a murine tuberculosis model.
Pandey R; Khuller GK
Chemotherapy; 2007; 53(6):437-41. PubMed ID: 17952004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
